CD8A and neoplasm: The released tumor antigens, and pathogen- and damage-associated molecular pattern molecules from lytic tumor cells could activate tumor-infiltrating antigen presenting cells which engulf, process and present antigens to effector immune cells, notably CD8+T lymphocytes (5, 6).